Shire Plc has secured additional time from the UK competition authority to review a proposed bid from Takeda Pharmaceutical Company Ltd that values the Dublin-based company at £46 billion. The parties have until 8 May to reach a decision. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals